A First-in-Human Phase 1 Safety and Biodistribution of [177Lu]Lu-ABY-271 in Subjects With HER2-positive Metastatic Breast Cancer

NCT07081555 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer
HER2 + Breast Cancer

Interventions

DRUG: [177Lu]Lu-ABY-271

Sponsor

Affibody